Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2024)

Illumina (ILMN) posted Asset Writedowns and Impairment of $1.9 billion for Q2 2024, up 31333.33% quarter-over-quarter from $6.0 million in Q4 2023.

Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2024) Analysis & Trends

Illumina (ILMN) has reported Asset Writedowns and Impairment for 4 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2024.

  • Asset Writedowns and Impairment for Q2 2024 came in at $1.9 billion, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $1.9 billion (down 30.48% YoY), and the FY2024 annual result was $1.9 billion, up 128.42% from the prior year.
  • Asset Writedowns and Impairment was $1.9 billion for Q2 2024 at Illumina, up from $6.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.9 billion in Q2 2024 and troughed at $6.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Quest Diagnostics 23.76 Bn 23.67 Bn 942.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 1.89 Bn
Jun 30, 2024 1.89 Bn
Dec 31, 2023 6.00 Mn
Dec 31, 2023 6.00 Mn
Oct 1, 2023 821.00 Mn
Oct 1, 2023 821.00 Mn
Apr 2, 2017 23.00 Mn
Apr 2, 2017 23.00 Mn
Jul 1, 2012 21.44 Mn
Jul 1, 2012 21.44 Mn